NCT05674240View on ClinicalTrials.gov

Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain

Active, not recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

December 6, 2022

Primary Completion Date

January 20, 2026

Study Completion Date

January 20, 2026

Conditions
Cancer PainChronic PainCancer Associated PainNeuropathic Pain
Interventions
DEVICE

Intrathecal Targeted Drug Delivery

Intrathecal drug delivery systems (IDDs) deliver small doses of analgesics directly to the spinal cord.

COMBINATION_PRODUCT

Conservative medical management

Including physical therapy, oral or transdermal medications and injections

Trial Locations (1)

54904

Advocate Aurora Health, Oshkosh

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER